• Explore /
  • Poster
  • / Phase II study of GM-CSF secreting allogeneic pancreatic cancer vaccine (GVAX) with PD-1 blockade antibody and stereotactic body radiation therapy (SBRT) for locally advanced pancreas cancer (LAPC).

Phase II study of GM-CSF secreting allogeneic pancreatic cancer vaccine (GVAX) with PD-1 blockade antibody and stereotactic body radiation therapy (SBRT) for locally advanced pancreas cancer (LAPC).

Abstract Poster

Authors

null

Valerie Lee

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD

Valerie Lee , Christina Rodriguez , Ella-Mae Shupe , Linda Chen , Rose Parkinson , Jennifer N. Durham , Elizabeth Sugar , Cara Wilt , Keith R. McIntyre , Amy Hacker-Prietz , Matthew J. Weiss , Jin He , Christopher Lee Wolfgang , Ana De Jesus-Acosta , Dung T. Le , Joseph M. Herman , Daniel A. Laheru , Amol Narang , Elizabeth M. Jaffee , Lei Zheng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT02648282

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS4154)

DOI

10.1200/JCO.2017.35.15_suppl.TPS4154

Abstract #

TPS4154

Poster Bd #

134b

Abstract Disclosures

Similar Posters

First Author: Valerie Lee

First Author: Andrew Oar

First Author: Vincent Chung

First Author: Jeesun Yoon